| Financial Year |
March 31 2023 |
| Monetary Funds |
571,570,775.52 |
| Held-for-trading Financial Assets |
94,885,996.47 |
| Notes Receivable |
-- |
| Accounts Receivable |
128,447,676.32 |
| Advances to Suppliers |
17,741,882.15 |
| Other Receivables |
44,047,103.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
146,557,287.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
38,197,582.52 |
| Total Current Assets |
1,041,448,304.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
24,231,415.58 |
| Investment Properties |
-- |
| Fixed Assetes |
80,185,101.22 |
| Under-construction Projects |
10,536,518.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
84,933,336.08 |
| R&D expenses |
-- |
| Goodwill |
197,016,596.22 |
| Long-Term Deferred and Prepaid Expenses |
7,106,654.26 |
| Deferred Income Tax Assets |
5,612,728.10 |
| Other Non-Current Assets |
26,049,721.55 |
| Sub-Total of Non-Current Assets |
515,517,149.59 |
| Total Assets |
1,556,965,454.51 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,890,000.00 |
| Accounts Payable |
42,439,046.46 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,420,997.37 |
| Taxes Payable |
733,950.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
99,215,125.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,748,862.67 |
| Other Current Liabilities |
9,077,852.58 |
| Sub-Total of Current Liabilities |
355,868,674.11 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
38,370,710.00 |
| Deferred Income Tax Liabilities |
20,593,218.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
125,119,061.22 |
| Total Liabilities |
480,987,735.33 |
| Paid-In Capital(Or Share Stock) |
345,752,939.00 |
| Capital Surplus |
536,200,818.67 |
| Surplus Reserve |
27,619,438.77 |
| LESS:Treasury Stock |
51,330,915.78 |
| Undistributed Profits |
199,188,274.23 |
| Minority Stockholder's Interest |
18,547,660.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,057,430,058.90 |
| Owner's Equity（Stockholder's Equity） |
1,075,977,719.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,556,965,454.51 |
